Nautilus Biotechnology IPO

Nautilus is a biotechnology company who is developing a proteomics platform enabling a dramatic acceleration of basic science research, significantly improving the success rate of therapeutic development, and enhancing opportunities for personalized and predictive medicine.

Register for Details

For more details on financing and valuation for Nautilus Biotechnology, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Nautilus Biotechnology's ticker symbol?


What is Nautilus Biotechnology's stock price?

3.16 as of 9/29/23

Learn more about Nautilus Biotechnology

Forge green plus iconForge green minus icon

When was Nautilus Biotechnology founded?

Nautilus Biotechnology was founded in 2021.
Updated on: Jun 12, 2022